PROTALIX BIOTHERAPEUTICS INC shareholders Q3 2023

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 62 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.0%.

PROTALIX BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Orin Green Financial, LLC 80,000$132,8000.07%
GSA CAPITAL PARTNERS LLP 496,781$8250.07%
DENALI ADVISORS LLC 110,200$182,9320.06%
XTX Topco Ltd 83,973$139,3950.02%
CAPITAL PERFORMANCE ADVISORS LLP 25,974$43,1170.02%
State of Wyoming 41,268$68,5050.02%
HARBOUR INVESTMENT MANAGEMENT LLC 10,100$16,7660.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 158,790$263,5910.01%
Truvestments Capital LLC 3,880$6,4410.00%
Renaissance Technologies 621,100$1,0310.00%
Virtu Financial LLC 11,184$190.00%
Aptus Capital Advisors, LLC 17,497$29,0450.00%
Connor, Clark & Lunn Investment Management Ltd. 167,536$278,1100.00%
SG Americas Securities, LLC 30,008$500.00%
Sculptor Capital LP 37,000$61,4200.00%
Sculptor Capital LP 37,000$61,4200.00%
Altshuler Shaham Ltd 12,142$20,1560.00%
AMERICAN INTERNATIONAL GROUP, INC. 33,107$54,9580.00%
BANK OF AMERICA CORP /DE/ 173,415$287,8690.00%
Russell Investments Group, Ltd. 2,764$4,5880.00%
External links

This page lists PROTALIX BIOTHERAPEUTICS INC's shareholders in Q3 2023. To view PROTALIX BIOTHERAPEUTICS INC's shareholder history, click here.